1 January 1970PatentsCaroline Pallard

The risk of narrow protection

A number of biotechnology inventions relate to peptides and other small molecules that could be used in therapeutic applications. Caroline Pallard explains the challenges of patenting such inventions.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

UK-India trade deal is ‘missed opportunity’, say industry bodies

WATCH: Recent developments in design patent law

SEPs now searchable on WIPO’s global patent database

'Nothing can stand in the way of our work': Ukraine resumes IP system

WATCH: Finding a new balance in IP protection with trade secret protection

Optis v Apple: How the court calculated the royalty rate

Apple must pay Optis $700m-the biggest patent award in UK history

Wouter Pors leaves Bird & Bird for boutique Dutch firm

The risk of narrow protection

Editor's picks

Editor's picks

More articles